BI Asset Management Fondsmaeglerselskab A S Makes New $946,000 Investment in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

BI Asset Management Fondsmaeglerselskab A S acquired a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 101,415 shares of the pharmacy operator's stock, valued at approximately $946,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. lifted its stake in shares of Walgreens Boots Alliance by 2.7% during the fourth quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator's stock worth $805,506,000 after purchasing an additional 2,279,495 shares in the last quarter. Invesco Ltd. lifted its position in Walgreens Boots Alliance by 8.8% during the 4th quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator's stock worth $303,902,000 after acquiring an additional 2,631,332 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Walgreens Boots Alliance by 5.2% in the 4th quarter. Geode Capital Management LLC now owns 20,779,254 shares of the pharmacy operator's stock worth $194,082,000 after acquiring an additional 1,020,587 shares during the period. Charles Schwab Investment Management Inc. grew its position in Walgreens Boots Alliance by 19.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator's stock valued at $122,737,000 after acquiring an additional 2,185,950 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $58,241,000. Institutional investors and hedge funds own 58.59% of the company's stock.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ:WBA traded down $0.02 on Friday, reaching $11.01. 6,349,910 shares of the company's stock were exchanged, compared to its average volume of 21,083,041. The business's 50-day moving average is $10.95 and its two-hundred day moving average is $10.22. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $18.83. The firm has a market capitalization of $9.52 billion, a price-to-earnings ratio of -1.08, a PEG ratio of 1.31 and a beta of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. The firm had revenue of $38.59 billion for the quarter, compared to analysts' expectations of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. Walgreens Boots Alliance's revenue was up 4.1% on a year-over-year basis. During the same quarter last year, the company posted $1.20 earnings per share. As a group, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Evercore ISI raised their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a report on Monday, January 13th. Bank of America raised their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research note on Monday, January 13th. Royal Bank of Canada boosted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a "sector perform" rating in a research note on Wednesday, January 15th. Truist Financial lowered their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Friday, January 31st. Finally, Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a "hold" rating to a "sell" rating and cut their target price for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.